Seeking Alpha

Needham downgrades Sagent Pharmaceuticals (SGNT -6.15%) on valuation, saying it's already...

Needham downgrades Sagent Pharmaceuticals (SGNT -6.15%) on valuation, saying it's already reached the 12-month price target set when it initiated coverage three weeks ago. The stock is up 62% since its April IPO.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|